BackAC Immune SA Overview

AC Immune SA Receivables

Latest receivables for ACIU: $1.5M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$1.51M
↓ 48.09% YoYΔ $-1.40M vs prior year quarter

Peer average

Loading

AC Immune SA Receivables History

Loading

AC Immune SA vs. peers: Receivables Comparison

Loading

AC Immune SA Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AC Immune SA (ACIU) FAQ

As of the most recent data (March 2026), ACIU shows a receivables of $1.5M. That compares with $2.9M in the prior-year period — down 48.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ACIU's receivables is now $1.5M (was $2.9M) — a 48.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether AC Immune SA is outperforming or lagging.

Tracking ACIU's receivables over time shows whether AC Immune SA is scaling, shrinking, or reshaping that part of the business. The current reading is $1.5M That compares with $2.9M in the prior-year period — down 48.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has AC Immune SA's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $1.5M) with ownership activity and broader fundamentals.

AC Immune SA's receivables is $1.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.